Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['carvykti']
important story and great reporting from and at #asco23 on the lingering challenges of getting car-t therapies to patients. so important in light of #carvykti's eye popping 74% reduction in disease progression or death. 
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA and emerging tech in biomedicine. Formerly at Boston Globe and C&EN